109 related articles for article (PubMed ID: 8144044)
1. Cerebral metabolic responses to meta-chlorophenylpiperazine are reduced during its chronic administration to young and aged rats.
Freo U; Larson DM; Soncrant TT
Gerontology; 1993; 39(6):305-13. PubMed ID: 8144044
[TBL] [Abstract][Full Text] [Related]
2. Time courses of behavioral and regional cerebral metabolic responses to different doses of meta-chlorophenylpiperazine in awake rats.
Freo U; Soncrant TT; Ricchieri GL; Wozniak KM; Larson DM; Rapoport SI
Brain Res; 1990 Mar; 511(2):209-16. PubMed ID: 2334843
[TBL] [Abstract][Full Text] [Related]
3. Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin.
Freo U; Holloway HW; Greig NH; Soncrant TT
Psychopharmacology (Berl); 1992; 107(1):30-8. PubMed ID: 1534179
[TBL] [Abstract][Full Text] [Related]
4. Age-related alterations in behavioral and cerebral metabolic responses to the serotonin agonist meta-chlorophenylpiperazine in rats.
Freo U; Rapoport SI; Soncrant TT
Neurobiol Aging; 1991; 12(2):137-44. PubMed ID: 2052128
[TBL] [Abstract][Full Text] [Related]
5. Parachloroamphetamine selectively alters regional cerebral metabolic responses to the serotonergic agonist metachlorophenylpiperazine in rats.
Freo U; Larson DM; Tolliver T; Rapoport SI; Soncrant TT
Brain Res; 1991 Mar; 544(1):17-25. PubMed ID: 1713115
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent effects of buspirone on behavior and cerebral glucose metabolism in rats.
Freo U; Pietrini P; Pizzolato G; Furey-Kurkjian M; Merico A; Ruggero S; Dam M; Battistin L
Brain Res; 1995 Apr; 677(2):213-20. PubMed ID: 7552245
[TBL] [Abstract][Full Text] [Related]
7. Cerebral metabolic effects of serotonin drugs and neurotoxins.
Freo U
Life Sci; 1996; 59(11):877-91. PubMed ID: 8795699
[TBL] [Abstract][Full Text] [Related]
8. The tricyclic antidepressant clomipramine dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats.
Freo U; Pietrini P; Dam M; Pizzolato G; Battistin L
Psychopharmacology (Berl); 1993; 113(1):53-9. PubMed ID: 7862829
[TBL] [Abstract][Full Text] [Related]
9. Cerebral metabolic responses to clomipramine are greatly reduced following pretreatment with the specific serotonin neurotoxin para-chloroamphetamine (PCA). A 2-deoxyglucose study in rats.
Freo U; Pietrini P; Pizzolato G; Furey M; Merico A; Ruggero S; Dam M; Battistin L
Neuropsychopharmacology; 1995 Nov; 13(3):215-22. PubMed ID: 8602894
[TBL] [Abstract][Full Text] [Related]
10. The 5-HT2C/2B receptor agonist m-chlorophenylpiperazine (mCPP) inhibits 2-deoxy-D-glucose (2-DG)-induced hyperphagia in rats.
Sugimoto Y; Yoshikawa T; Noma T; Yamada J
Biol Pharm Bull; 2001 Dec; 24(12):1431-3. PubMed ID: 11767117
[TBL] [Abstract][Full Text] [Related]
11. Effects of m-chlorophenylpiperazine on regional brain glucose utilization: a positron emission tomographic comparison of alcoholic and control subjects.
Hommer D; Andreasen P; Rio D; Williams W; Ruttimann U; Momenan R; Zametkin A; Rawlings R; Linnoila M
J Neurosci; 1997 Apr; 17(8):2796-806. PubMed ID: 9092601
[TBL] [Abstract][Full Text] [Related]
12. Adrenalectomy or metyrapone-pretreatment abolishes cerebral metabolic responses to the serotonin agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the hippocampus.
Freo U; Holloway HW; Kalogeras K; Rapoport SI; Soncrant TT
Brain Res; 1992 Jul; 586(2):256-64. PubMed ID: 1521159
[TBL] [Abstract][Full Text] [Related]
13. Dose- and time-dependent effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a serotonergic 5-HT2 receptor agonist, on local cerebral glucose metabolism in awake rats.
Freo U; Soncrant TT; Holloway HW; Rapoport SI
Brain Res; 1991 Feb; 541(1):63-9. PubMed ID: 2029625
[TBL] [Abstract][Full Text] [Related]
14. Effects of anesthesia and recovery from ketamine racemate and enantiomers on regional cerebral glucose metabolism in rats.
Freo U; Ori C
Anesthesiology; 2004 May; 100(5):1172-8. PubMed ID: 15114215
[TBL] [Abstract][Full Text] [Related]
15. Time- and dose-dependent effects of the serotonergic agent quipazine on regional cerebral metabolism in rats.
Freo U; Ricchieri GL; Holloway HW; Soncrant TT
Brain Res; 1993 Jan; 600(2):249-56. PubMed ID: 8435750
[TBL] [Abstract][Full Text] [Related]
16. Intravenous administration of the serotonin agonist m-chlorophenylpiperazine (mCPP) increases extracellular serotonin in the diencephalon of awake rats.
Baumann MH; Rutter JJ; Auerbach SB
Neuropharmacology; 1993 Dec; 32(12):1381-6. PubMed ID: 8152528
[TBL] [Abstract][Full Text] [Related]
17. Effect of meta-chlorophenylpiperazine (mCPP), a central serotonin agonist and vascular serotonin receptor antagonist, on blood pressure in SHR.
Cohen ML; Kurz KD; Fuller RW
Clin Exp Hypertens A; 1987; 9(10):1549-65. PubMed ID: 3677442
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic and serotonergic modulation of persistent behaviour in the reinforced spatial alternation model of obsessive-compulsive disorder.
Kontis D; Boulougouris V; Papakosta VM; Kalogerakou S; Papadopoulos S; Poulopoulou C; Papadimitriou GN; Tsaltas E
Psychopharmacology (Berl); 2008 Nov; 200(4):597-610. PubMed ID: 18622751
[TBL] [Abstract][Full Text] [Related]
19. Effects of acute and chronic treatment with fluoxetine on regional glucose cerebral metabolism in rats: implications for clinical therapies.
Freo U; Ori C; Dam M; Merico A; Pizzolato G
Brain Res; 2000 Jan; 854(1-2):35-41. PubMed ID: 10784104
[TBL] [Abstract][Full Text] [Related]
20. Chronic lithium chloride administration to rats elevates glucose metabolism in wide areas of brain, while potentiating negative effects on metabolism of dopamine D2-like receptor stimulation.
Basselin M; Chang L; Rapoport SI
Psychopharmacology (Berl); 2006 Aug; 187(3):303-11. PubMed ID: 16786332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
